Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma

Author：            

Publisher： Spandidos Publications

ISSN： 2049-9442

Source： Biomedical Reports, Vol.1, Iss.5, 2013-01, pp. : 771-775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Association of genetic variants in the interleukin‐18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection

By  

IUBMB LIFE, Vol. 70, Iss. 2, 2018-02 ,pp. : 165-174

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 90, Iss. 3, 2018-03 ,pp. : 490-496

John Wiley & Sons Inc

Access to resources Recommend Favorite

DNMT3A -448A>G polymorphism and the risk for hepatocellular carcinoma

By            

Biomedical Reports, Vol. 1, Iss. 4, 2013-01 ,pp. : 664-668

Spandidos Publications

Access to resources Recommend Favorite

Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for renal cell carcinoma

By Zhang Junxia   Guo Zhanjun   Bai Yaling   Cui Liwen   Zhang Shenglei   Xu Jinsheng  

Biomedical Reports, Vol. 1, Iss. 4, 2013-07 ,pp. : 563-566

Spandidos Publications

Access to resources Recommend Favorite

Genetic variation in arsenic (+3 oxidation state) methyltransferase (AS3MT), arsenic metabolism and risk of basal cell carcinoma in a European population

By  

ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (ELECTRONIC), Vol. 56, Iss. 1, 2015-01 ,pp. : 60-69

John Wiley & Sons Inc

Access to resources Recommend Favorite